Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bearish
5 minConsolidating
Daily trend turns down below $2.58
Key levels
Resistance$5.60
Resistance$5.10
Support$4.48
Support$3.99
Latest news & SEC filings
SEC FilingShuttle Pharmaceuticals Holdings, Inc. filed a report on a major company event (Form 8-K)
All SHPH news →Shuttle Pharmaceuticals is a pharmaceutical company centered on using artificial intelligence to help find new drug candidates and support the earliest phases of pharmaceutical research. Its Molecule.ai platform offers tools for predicting molecular properties, comparing compounds across multiple attributes, and generating structured scientific interpretations for research teams. The company had been developing Ropidoxuridine as a radiation sensitizer for cancer treatment but has ended its clinical testing. It operates in the United States and serves pharmaceutical research and development organizations.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SHPH.
Start Free Trial →Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
0
Moat Score
NONE
2/9
Piotroski Score
-10.2
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
91.33%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for SHPH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:24:38 | $5.00 | 1,500 | $$8K | BUY |
| 16:24:32 | $5.00 | 1,500 | $$8K | BUY |
| 16:24:21 | $5.00 | 1,500 | $$8K | BUY |
| 16:23:52 | $5.00 | 3,100 | $$16K | BUY |
| 15:15:51 | $5.33 | 2,392 | $$13K | SELL |
5 dark pool trades shown · $$51K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is at $4.90, down 6.67% (-$0.35) at the Nov 12, 2026 close.
Latest SHPH news — Nov 6, 2026: Shuttle Pharmaceuticals Holdings, Inc. filed a report on a major company event (Form 8-K)
SHPH last reported on Sep 24, 2026: EPS -$3.84.
SHPH trades at a P/E of 0.2 vs a Healthcare average of 17.7.
SHPH does not currently pay a dividend.
Support: $4.48, $3.99, $3.32. Resistance: $5.10, $5.60, $6.55.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 6, 2026: Shuttle Pharmaceuticals Holdings, Inc. filed a report on a major company event (Form 8-K)